Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386052117> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4386052117 endingPage "4238" @default.
- W4386052117 startingPage "4234" @default.
- W4386052117 abstract "Advances in preoperative chemoradiotherapy and surgical techniques offered improvements in rates of locoregional recurrence but did not address distant metastasis. Traditionally, adjuvant chemotherapy has been administered with the goal of limiting systemic recurrences.Evaluation of the efficacy and safety of adjuvant chemotherapy in patients with locally advanced rectal cancer after preoperative chemoradiotherapy and surgery.From January 2017 to December 2018, 103 patients diagnosed with clinical stage II or III rectal cancer received adjuvant chemotherapy with capecitabine or XELOX regimens after neoadjuvant concurrent chemoradiotherapy and total mesorectal excision. Overall survival, disease-free survival, and toxicity were analyzed.The median follow-up time was 52.5 months (6.5-66.8 months). The mean 3-year disease-free survival and 3-year overall survival were 86.2% (95% CI: 82.8-89.6) and 92.2% (95% CI: 86.9-97.5), respectively. The rate of hematologic and nonhematologic toxicity was low, mostly grades 1 and 2 including anemia, leucopenia, thrombocytopenia, and liver enzymes elevations were 85.4, 50.5, 42.8, and 45.6%, respectively.The capecitabine and XELOX regimen in adjuvant settings for rectal cancer patients receiving neoadjuvant chemoradiotherapy and surgery was a safe and effective modality. Further randomized trials need to be conducted to evaluate the role of postoperative therapy for these individuals." @default.
- W4386052117 created "2023-08-23" @default.
- W4386052117 creator A5004119517 @default.
- W4386052117 creator A5010741873 @default.
- W4386052117 creator A5044844829 @default.
- W4386052117 creator A5090006461 @default.
- W4386052117 date "2023-09-01" @default.
- W4386052117 modified "2023-09-23" @default.
- W4386052117 title "Adjuvant chemotherapy in locally advanced rectal cancer after neo-adjuvant concurrent chemoradiotherapy and surgery: A study in Vietnamese patients" @default.
- W4386052117 cites W2097656606 @default.
- W4386052117 cites W2099764000 @default.
- W4386052117 cites W2106014206 @default.
- W4386052117 cites W2121294912 @default.
- W4386052117 cites W2122262640 @default.
- W4386052117 cites W2123377696 @default.
- W4386052117 cites W2124297369 @default.
- W4386052117 cites W2124886112 @default.
- W4386052117 cites W2168083201 @default.
- W4386052117 cites W2594373254 @default.
- W4386052117 cites W2801952873 @default.
- W4386052117 cites W2997246358 @default.
- W4386052117 cites W3002951017 @default.
- W4386052117 cites W3015022554 @default.
- W4386052117 cites W3046189029 @default.
- W4386052117 cites W3212282753 @default.
- W4386052117 cites W4307503400 @default.
- W4386052117 doi "https://doi.org/10.1097/ms9.0000000000001101" @default.
- W4386052117 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37674661" @default.
- W4386052117 hasPublicationYear "2023" @default.
- W4386052117 type Work @default.
- W4386052117 citedByCount "0" @default.
- W4386052117 crossrefType "journal-article" @default.
- W4386052117 hasAuthorship W4386052117A5004119517 @default.
- W4386052117 hasAuthorship W4386052117A5010741873 @default.
- W4386052117 hasAuthorship W4386052117A5044844829 @default.
- W4386052117 hasAuthorship W4386052117A5090006461 @default.
- W4386052117 hasBestOaLocation W43860521171 @default.
- W4386052117 hasConcept C121608353 @default.
- W4386052117 hasConcept C126322002 @default.
- W4386052117 hasConcept C141071460 @default.
- W4386052117 hasConcept C143998085 @default.
- W4386052117 hasConcept C2776694085 @default.
- W4386052117 hasConcept C2777201421 @default.
- W4386052117 hasConcept C2777909004 @default.
- W4386052117 hasConcept C2778424827 @default.
- W4386052117 hasConcept C2781413609 @default.
- W4386052117 hasConcept C526805850 @default.
- W4386052117 hasConcept C71924100 @default.
- W4386052117 hasConceptScore W4386052117C121608353 @default.
- W4386052117 hasConceptScore W4386052117C126322002 @default.
- W4386052117 hasConceptScore W4386052117C141071460 @default.
- W4386052117 hasConceptScore W4386052117C143998085 @default.
- W4386052117 hasConceptScore W4386052117C2776694085 @default.
- W4386052117 hasConceptScore W4386052117C2777201421 @default.
- W4386052117 hasConceptScore W4386052117C2777909004 @default.
- W4386052117 hasConceptScore W4386052117C2778424827 @default.
- W4386052117 hasConceptScore W4386052117C2781413609 @default.
- W4386052117 hasConceptScore W4386052117C526805850 @default.
- W4386052117 hasConceptScore W4386052117C71924100 @default.
- W4386052117 hasIssue "9" @default.
- W4386052117 hasLocation W43860521171 @default.
- W4386052117 hasLocation W43860521172 @default.
- W4386052117 hasOpenAccess W4386052117 @default.
- W4386052117 hasPrimaryLocation W43860521171 @default.
- W4386052117 hasRelatedWork W2029040122 @default.
- W4386052117 hasRelatedWork W2102886345 @default.
- W4386052117 hasRelatedWork W2118931028 @default.
- W4386052117 hasRelatedWork W2139955290 @default.
- W4386052117 hasRelatedWork W2145753255 @default.
- W4386052117 hasRelatedWork W2362524478 @default.
- W4386052117 hasRelatedWork W2404294814 @default.
- W4386052117 hasRelatedWork W2410585190 @default.
- W4386052117 hasRelatedWork W2601851885 @default.
- W4386052117 hasRelatedWork W349909140 @default.
- W4386052117 hasVolume "85" @default.
- W4386052117 isParatext "false" @default.
- W4386052117 isRetracted "false" @default.
- W4386052117 workType "article" @default.